[1] Rakha EA, Ellis IO. Diagnostic challenges in papillary lesions of the breast. Pathology. 2018. 50(1): 100-110.
[2] Guray M, Sahin AA. Benign breast diseases: classification, diagnosis, and management. Oncologist. 2006. 11(5): 435-49.
[3] Nakhlis F, Ahmadiyeh N, Lester S, Raza S, Lotfi P, Golshan M. Papilloma on core biopsy: excision vs. observation. Ann Surg Oncol. 2015. 22(5): 1479-82.
[4] Collins LC, Schnitt SJ. Papillary lesions of the breast: selected diagnostic and management issues. Histopathology. 2008. 52(1): 20-9.
[5] Tran HT, Mursleen A, Mirpour S, Ghanem O, Farha MJ. Papillary Breast Lesions: Association with Malignancy and Upgrade Rates on Surgical Excision. Am Surg. 2017. 83(11): 1294-1297.
[6] Karadeniz E, Arslan S, Akcay MN, Subaşi ID, Demirci E. Papillary Lesions of Breast. Chirurgia (Bucur). 2016. 111(3): 225-9.
[7] MacGrogan G, Tavassoli FA. Central atypical papillomas of the breast: a clinicopathological study of 119 cases. Virchows Arch. 2003. 443(5): 609-17.
[8] Tavassoli FA. Lobular and ductal intraepithelial neoplasia. Pathologe. 2008. 29 Suppl 2: 107-11.
[9] Tavassoli FA. Breast pathology: rationale for adopting the ductal intraepithelial neoplasia (DIN) classification. Nat Clin Pract Oncol. 2005. 2(3): 116-7.
[10] Sakai T, Makita M, Akiyama F, et al. Intraductal papilloma with bloody discharge from Montgomery's areolar tubercle examined by ductoscopy from the areola. Breast Cancer. 2006. 13(1): 104-6.
[11] Shiino S, Tsuda H, Yoshida M, et al. Intraductal papillomas on core biopsy can be upgraded to malignancy on subsequent excisional biopsy regardless of the presence of atypical features. Pathol Int. 2015. 65(6): 293-300.
[12] Kibil W, Hodorowicz-Zaniewska D, Popiela TJ, Szpor J, Kulig J. Mammotome biopsy in diagnosing and treatment of intraductal papilloma of the breast. Pol Przegl Chir. 2013. 85(4): 210-5.
[13] Ahmadiyeh N, Stoleru MA, Raza S, Lester SC, Golshan M. Management of intraductal papillomas of the breast: an analysis of 129 cases and their outcome. Ann Surg Oncol. 2009. 16(8): 2264-9.
[14] Renshaw AA, Derhagopian RP, Tizol-Blanco DM, Gould EW. Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision. Am J Clin Pathol. 2004. 122(2): 217-21.
[15] Wilson R, Kavia S. Comparison of large-core vacuum-assisted breast biopsy and excision systems. Recent Results Cancer Res. 2009. 173: 23-41.
[16] Youk JH, Kim EK, Kim MJ, Lee JY, Oh KK. Missed breast cancers at US-guided core needle biopsy: how to reduce them. Radiographics. 2007. 27(1): 79-94.
[17] Puglisi F, Zuiani C, Bazzocchi M, et al. Role of mammography, ultrasound and large core biopsy in the diagnostic evaluation of papillary breast lesions. Oncology. 2003. 65(4): 311-5.
[18] Al HT, Delli FP, El-Khoury M, Joseph L, Zheng J, Mesurolle B. Accuracy of percutaneous core needle biopsy in diagnosing papillary breast lesions and potential impact of sonographic features on their management. J Clin Ultrasound. 2013. 41(1): 1-9.
[19] Mercado CL, Hamele-Bena D, Oken SM, Singer CI, Cangiarella J. Papillary lesions of the breast at percutaneous core-needle biopsy. Radiology. 2006. 238(3): 801-8.
[20] Wen X, Cheng W. Nonmalignant breast papillary lesions at core-needle biopsy: a meta-analysis of underestimation and influencing factors. Ann Surg Oncol. 2013. 20(1): 94-101.
[21] Donaldson AR, McCarthy C, Goraya S, et al. Breast cancer risk associated with atypical hyperplasia and lobular carcinoma in situ initially diagnosed on core-needle biopsy. Cancer. 2017 .
[22] Hartmann LC, Degnim AC, Santen RJ, Dupont WD, Ghosh K. Atypical hyperplasia of the breast--risk assessment and management options. N Engl J Med. 2015. 372(1): 78-89.
[23] Nayak A, Carkaci S, Gilcrease MZ, et al. Benign papillomas without atypia diagnosed on core needle biopsy: experience from a single institution and proposed criteria for excision. Clin Breast Cancer. 2013. 13(6): 439-49.
[24] Swapp RE, Glazebrook KN, Jones KN, et al. Management of benign intraductal solitary papilloma diagnosed on core needle biopsy. Ann Surg Oncol. 2013. 20(6): 1900-5.
[25] Linda A, Zuiani C, Furlan A, et al. Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI. AJR Am J Roentgenol. 2012. 198(2): 272-80.
[26] Carder PJ, Garvican J, Haigh I, Liston JC. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast. Histopathology. 2005. 46(3): 320-7.
[27] Agoff SN, Lawton TJ. Papillary lesions of the breast with and without atypical ductal hyperplasia: can we accurately predict benign behavior from core needle biopsy. Am J Clin Pathol. 2004. 122(3): 440-3.
[28] Rosen EL, Bentley RC, Baker JA, Soo MS. Imaging-guided core needle biopsy of papillary lesions of the breast. AJR Am J Roentgenol. 2002. 179(5): 1185-92.
[29] Glenn ME, Throckmorton AD, Thomison JB, Bienkowski RS. Papillomas of the breast 15 mm or smaller: 4-year experience in a community-based dedicated breast imaging clinic. Ann Surg Oncol. 2015. 22(4): 1133-9.
[30] Fu CY, Chen TW, Hong ZJ, et al. Papillary breast lesions diagnosed by core biopsy require complete excision. Eur J Surg Oncol. 2012. 38(11): 1029-35.
[31] Tseng HS, Chen YL, Chen ST, et al. The management of papillary lesion of the breast by core needle biopsy. Eur J Surg Oncol. 2009. 35(1): 21-4.
[32] Shamonki J, Chung A, Huynh KT, Sim MS, Kinnaird M, Giuliano A. Management of papillary lesions of the breast: can larger core needle biopsy samples identify patients who may avoid surgical excision. Ann Surg Oncol. 2013. 20(13): 4137-44.
[33] Kim SY, Kim EK, Lee HS, et al. Asymptomatic Benign Papilloma Without Atypia Diagnosed at Ultrasonography-Guided 14-Gauge Core Needle Biopsy: Which Subgroup can be Managed by Observation. Ann Surg Oncol. 2016. 23(6): 1860-6.
[34] Kim MJ, Kim SI, Youk JH, et al. The diagnosis of non-malignant papillary lesions of the breast: comparison of ultrasound-guided automated gun biopsy and vacuum-assisted removal. Clin Radiol. 2011. 66(6): 530-5.
[35] Shin HJ, Kim HH, Kim SM, et al. Papillary lesions of the breast diagnosed at percutaneous sonographically guided biopsy: comparison of sonographic features and biopsy methods. AJR Am J Roentgenol. 2008. 190(3): 630-6.
[36] Preibsch H, Baur A, Wietek BM, et al. Vacuum-assisted breast biopsy with 7-gauge, 8-gauge, 9-gauge, 10-gauge, and 11-gauge needles: how many specimens are necessary. Acta Radiol. 2015. 56(9): 1078-84.
[37] Youk JH, Kim EK, Kwak JY, Son EJ. Atypical papilloma diagnosed by sonographically guided 14-gauge core needle biopsy of breast mass. AJR Am J Roentgenol. 2010. 194(5): 1397-402.
[38] Pfleiderer SO, Brunzlow H, Schulz-Wendtland R, et al. Two-year follow-up of stereotactically guided 9-G breast biopsy: a multicenter evaluation of a self-contained vacuum-assisted device. Clin Imaging. 2009. 33(5): 343-7.
[39] Georgian-Smith D, Lawton TJ. Controversies on the management of high-risk lesions at core biopsy from a radiology/pathology perspective. Radiol Clin North Am. 2010. 48(5): 999-1012.
[40] Lewis JT, Hartmann LC, Vierkant RA, et al. An analysis of breast cancer risk in women with single, multiple, and atypical papilloma. Am J Surg Pathol. 2006. 30(6): 665-72.
[41] Debnath D, Al-Okati D, Ismail W. Multiple Papillomatosis of Breast and Patient's Choice of Treatment. Patholog Res Int. 2010. 2010: 540590.
[42] Muttarak M, Lerttumnongtum P, Chaiwun B, Peh WC. Spectrum of papillary lesions of the breast: clinical, imaging, and pathologic correlation. AJR Am J Roentgenol. 2008. 191(3): 700-7.
[43] Yi W, Xu F, Zou Q, Tang Z. Completely removing solitary intraductal papillomas using the Mammotome system guided by ultrasonography is feasible and safe. World J Surg. 2013. 37(11): 2613-7.
[44] Zhu Y, Zhang S, Liu P, Lu H, Xu Y, Yang WT. Solitary intraductal papillomas of the breast: MRI features and differentiation from small invasive ductal carcinomas. AJR Am J Roentgenol. 2012. 199(4): 936-42.
[45] Kil WH, Cho EY, Kim JH, Nam SJ, Yang JH. Is surgical excision necessary in benign papillary lesions initially diagnosed at core biopsy. Breast. 2008. 17(3): 258-62.
[46] Rizzo M, Lund MJ, Oprea G, Schniederjan M, Wood WC, Mosunjac M. Surgical follow-up and clinical presentation of 142 breast papillary lesions diagnosed by ultrasound-guided core-needle biopsy. Ann Surg Oncol. 2008. 15(4): 1040-7.
[47] Bernik SF, Troob S, Ying BL, et al. Papillary lesions of the breast diagnosed by core needle biopsy: 71 cases with surgical follow-up. Am J Surg. 2009. 197(4): 473-8.
[48] Jaffer S, Nagi C, Bleiweiss IJ. Excision is indicated for intraductal papilloma of the breast diagnosed on core needle biopsy. Cancer. 2009. 115(13): 2837-43.
[49] Cheng TY, Chen CM, Lee MY, et al. Risk factors associated with conversion from nonmalignant to malignant diagnosis after surgical excision of breast papillary lesions. Ann Surg Oncol. 2009. 16(12): 3375-9.
[50] Jung SY, Kang HS, Kwon Y, et al. Risk factors for malignancy in benign papillomas of the breast on core needle biopsy. World J Surg. 2010. 34(2): 261-5.
[51] Youk JH, Kim EK, Kwak JY, Son EJ, Park BW, Kim SI. Benign papilloma without atypia diagnosed at US-guided 14-gauge core-needle biopsy: clinical and US features predictive of upgrade to malignancy. Radiology. 2011. 258(1): 81-8.
[52] Chang JM, Han W, Moon WK, et al. Papillary lesions initially diagnosed at ultrasound-guided vacuum-assisted breast biopsy: rate of malignancy based on subsequent surgical excision. Ann Surg Oncol. 2011. 18(9): 2506-14.
[53] Rozentsvayg E, Carver K, Borkar S, Mathew M, Enis S, Friedman P. Surgical excision of benign papillomas diagnosed with core biopsy: a community hospital approach. Radiol Res Pract. 2011. 2011: 679864.
[54] Rizzo M, Linebarger J, Lowe MC, et al. Management of papillary breast lesions diagnosed on core-needle biopsy: clinical pathologic and radiologic analysis of 276 cases with surgical follow-up. J Am Coll Surg. 2012. 214(3): 280-7.
[55] Jakate K, De Brot M, Goldberg F, Muradali D, O'Malley FP, Mulligan AM. Papillary lesions of the breast: impact of breast pathology subspecialization on core biopsy and excision diagnoses. Am J Surg Pathol. 2012. 36(4): 544-51.
[56] Lu Q, Tan EY, Ho B, Chen JJ, Chan PM. Surgical excision of intraductal breast papilloma diagnosed on core biopsy. ANZ J Surg. 2012. 82(3): 168-72.
[57] Kim WH, Chang JM, Moon WK, et al. Intraductal mass on breast ultrasound: final outcomes and predictors of malignancy. AJR Am J Roentgenol. 2013. 200(4): 932-7.
[58] Foley NM, Racz JM, Al-Hilli Z, et al. An International Multicenter Review of the Malignancy Rate of Excised Papillomatous Breast Lesions. Ann Surg Oncol. 2015. 22 Suppl 3: S385-90.
[59] Boufelli G, Giannotti MA, Ruiz CA, et al. Papillomas of the breast: factors associated with underestimation. Eur J Cancer Prev. 2017 .
[60] Niinikoski L, Hukkinen K, MHK L, Ståhls A, Meretoja TJ. Breast Lesion Excision System in the diagnosis and treatment of intraductal papillomas - A feasibility study. Eur J Surg Oncol. 2018. 44(1): 59-66.